Germany’s science minister says the same safety standards are being applied in the approval process for coronavirus vaccines as for other drugs.
Anja Karliczek told reporters on Tuesday that ensuring the same standards is key to gaining the widest possible public acceptance for the COVID vaccine.
Karliczek noted that the European Medicines Agency will be holding a public hearing on Dec. 11 on an approval request by German pharmaceutical company BioNTech and its U.S. partner Pfizer.
She added that the vaccine will be voluntary and that authorities will work hard to inform the public about possible side effects that might be excepted after immunization, such as headaches, localized pain and fever.
Marylyn Addo, a doctor at Hamburg’s UKE hospital who is involved in the trials for a rival vaccine, said that the rapid development of a vaccine was the result of enormous efforts by scientists, early funding and experience from previous vaccines.